[1] | Wu H, Zhang Y. Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell, 2014, 156(1-2): 45-68. | [2] | Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science, 2009, 324(5929): 929-930. | [3] | Tahiliani M, Koh KP, Shen YH, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, Rao A. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science, 2009, 324(5929): 930-935. | [4] | Ito S, D'alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature, 2010, 466(7310): 1129-1133. | [5] | Lian CG, Xu YF, Ceol C, Wu FZ, Larson A, Dresser K, Xu WQ, Tan L, Hu YG, Zhan Q, Lee CW, Hu D, Lian BQ, Kleffel S, Yang YJ, Neiswender J, Khorasani AJ, Fang R, Lezcano C, Duncan LM, Scolyer RA, Thompson JF, Kakavand H, Houvras Y, Zon LI, Mihm MC Jr, Kaiser UB, Schatton T, Woda BA, Murphy GF, Shi YG. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell, 2012, 150(6): 1135-1146. | [6] | Wyatt GR, Cohen SS. A new pyrimidine base from bacteriophage nucleic acids. Nature, 1952, 170(4338): 1072-1073. | [7] | Ko M, Huang Y, Jankowska AM, Pape UJ, Tahiliani M, Bandukwala HS, An J, Lamperti ED, Koh KP, Ganetzky R, Liu XS, Aravind L, Agarwal S, Maciejewski JP, Rao A. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature, 2010, 468(7325): 839-843. | [8] | Ono R, Taki T, Taketani T, Taniwaki M, Kobayashi H, Hayashi Y. LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10; 11)(q22; q23). Cancer Res, 2002, 62(14): 4075-4080. | [9] | Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, He C, Zhang Y. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science, 2011, 333(6047): 1300-1303. | [10] | He YF, Li BZ, Li Z, Liu P, Wang Y, Tang QY, Ding JP, Jia YY, Chen ZC, Li L, Sun Y, Li XX, Dai Q, Song CX, Zhang K, He C, Xu GL. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science, 2011, 333(6047): 1303-1307. | [11] | Deng DJ. DNA methylation and demethylation: current status and future per-spective. Hereditas (Beijing), 2014, 36(5): 403-410. | [11] | 邓大君. DNA甲基化和去甲基化的研究现状及思考. 遗传, 2014, 36(5): 403-410. | [12] | Xu YF, Wu FZ, Tan L, Kong LC, Xiong LJ, Deng J, Barbera AJ, Zheng LJ, Zhang HK, Huang S, Min JR, Nicholson T, Chen TP, Xu GL, Shi Y, Zhang K, Shi YG. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase |
[1] |
韩熙, 罗富成. 单细胞转录组测序在少突胶质谱系细胞异质性与神经系统疾病中的应用[J]. 遗传, 2023, 45(3): 198-211. |
[2] |
赵岩, 王晨鑫, 杨天明, 李春爽, 张丽宏, 杜冬妮, 王若曦, 王静, 魏民, 巴雪青. DNA氧化损伤8-羟鸟嘌呤与肿瘤的发生发展[J]. 遗传, 2022, 44(6): 466-477. |
[3] |
何江平, 陈捷凯. 转座元件、表观遗传调控与细胞命运决定[J]. 遗传, 2021, 43(9): 822-834. |
[4] |
崔婷婷, 邢天宇, 褚衍凯, 李辉, 王宁. PPARγ在脂肪生成中的遗传和表观遗传调控[J]. 遗传, 2017, 39(11): 1066-1077. |
[5] |
方科, 张凯翔, 王建, 付志猛, 赵湘辉. 表观遗传学新标记--5-羟甲基胞嘧啶检测方法的研究进展[J]. 遗传, 2016, 38(3): 206-216. |
[6] |
张燕霞,高可润,禹顺英. 5-羟甲基胞嘧啶的研究进展[J]. 遗传, 2012, 34(5): 509-518. |
[7] |
葛少钦,李建忠,张晓静. 精子发生过程中组蛋白甲基化和乙酰化[J]. 遗传, 2011, 33(9): 939-946. |
[8] |
顾娟,陈晓萍. 神经发育中的细胞周期时程[J]. 遗传, 2011, 33(11): 1185-1190. |
[9] |
冯碧薇,陈建强,雷秉坤,潘贤,吕红. 酵母模式生物研究表观遗传调控基因组稳定性的进展[J]. 遗传, 2010, 32(8): 799-807. |
[10] |
盛伟,马端. 组蛋白赖氨酸甲基化修饰与先天性心脏病研究进展[J]. 遗传, 2010, 32(7): 650-655. |
|